Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Apr;86(8):2794-8.
doi: 10.1073/pnas.86.8.2794.

Mutations in RNA polymerase II enhance or suppress mutations in GAL4

Affiliations

Mutations in RNA polymerase II enhance or suppress mutations in GAL4

L A Allison et al. Proc Natl Acad Sci U S A. 1989 Apr.

Abstract

The activation domains of eukaryotic DNA-binding transcription factors, such as GAL4, may regulate transcription by contacting RNA polymerase II. One potential site on RNA polymerase II for such interactions is the C-terminal tandemly repeated heptapeptide domain in the largest subunit (RPO21). We have changed the number of heptapeptide repeats in this yeast RPO21 C-terminal domain and have expressed these mutant RNA polymerase II polypeptides in yeast cells containing either wild-type or defective GAL4 proteins. Although the number of RPO21 heptapeptide repeats had no effect on the activity of wild-type GAL4, changing the length of the C-terminal domain modified the ability of mutant GAL4 proteins to activate transcription. Shorter or longer RPO21 C-terminal domains enhanced or partially suppressed, respectively, the effects of deletions in the transcriptional-activation domains of GAL4. The same RPO21 mutations also affected transcriptional activation by a GAL4-GCN4 chimera. These data suggest that the activation domains of DNA-binding transcription factors could interact, either directly or indirectly, with the heptapeptide repeats of RNA polymerase II.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Gene. 1980 Jul;10(2):157-66 - PubMed
    1. Nature. 1989 Feb 16;337(6208):666-8 - PubMed
    1. J Biol Chem. 1982 Nov 10;257(21):13042-7 - PubMed
    1. J Bacteriol. 1983 Jan;153(1):163-8 - PubMed
    1. J Biol Chem. 1983 Feb 25;258(4):2303-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources